NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NRSN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $6.79M
- EPS (TTM)
- -$47.10
- Dividend yield
- None
- 52-week range
- 3.56 – 26.64
- Day range
- 3.56 – 3.90
- Volume / Avg
- 15.80K / 21.08K
- Beta
- —
- Shares outstanding
- 1.90M
52-week range
NRSN stock today
Shares of NeuroSense Therapeutics (NRSN) finished lower on Oct 8 at $3.58, a drop of 6.28% or $0.24 per share, versus the S&P 500's 0.47% decline. Shares are 86.6% below their 52-week high of $26.64 and 0.5% above the 52-week low of $3.56, near the bottom of the past year's range. NeuroSense Therapeutics has posted a net loss over the last twelve months (EPS of -$47.10), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About NeuroSense Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
NeuroSense Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INMInMed Pharmaceuticals Inc. | 1.33 | 0.00% | $7.31M | vs NRSN |
| MDCXMedicus Pharma Ltd. | 0.1019 | -36.39% | $7.31M | vs NRSN |
| TRAWTraws Pharma Inc. | 0.4803 | +0.27% | $7.38M | vs NRSN |
| SKYESkye Bioscience Inc. | 1.68 | +1.82% | $7.44M | vs NRSN |
| BOLTBolt Biotherapeutics Inc. | 3.65 | +1.39% | $7.03M | vs NRSN |
| APREAprea Therapeutics Inc. | 0.5582 | -7.74% | $7.03M | vs NRSN |
| CURXCuranex Pharmaceuticals Inc | 4.76 | -0.94% | $7.46M | vs NRSN |
| ACXPAcurx Pharmaceuticals Inc. | 1.25 | -3.85% | $6.95M | vs NRSN |
Indexes, lists and sector
NeuroSense Therapeutics stock FAQ
What is NeuroSense Therapeutics's stock price today?
NRSN last traded at $3.58 as of Oct 8, 4:00 PM EDT, down 6.28% on the day. Prices are delayed at least 15 minutes.
What is the NRSN 52-week high?
The 52-week high for NRSN is $26.64 and the 52-week low is $3.56. The stock is currently 86.6% below its high.